These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1650110)

  • 1. [Indicators of prostaglandin synthase activity in thrombocytes of patients with schizophrenia with positive and negative disorders].
    Geling NG; Klimenko TV; Milekhin GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):99-101. PubMed ID: 1650110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methodological approaches to evaluation of prostaglandin synthesis by isolated human thrombocytes].
    Geling NG
    Vopr Med Khim; 1990; 36(2):83-6. PubMed ID: 2114053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipoperoxides and cyclooxygenase activity in thrombocytes in relation to the age of healthy subjects and drugs affecting prostaglandin biosynthesis (Acylpyrin, Indren, Erevit forte)].
    Prikryl P; Rysánek K; Továrek J; Vojtková J; Prikrylová I
    Cas Lek Cesk; 1980 May; 119(22):621-6. PubMed ID: 6775810
    [No Abstract]   [Full Text] [Related]  

  • 6. [The deficit syndrome: a domain of schizophrenia].
    Arango C; Kirkpatrick B; Buchanan RW; Carpenter WT
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):180-6. PubMed ID: 9717343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
    Patrignani P; Panara MR; Greco A; Fusco O; Natoli C; Iacobelli S; Cipollone F; Ganci A; Créminon C; Maclouf J
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():129-31. PubMed ID: 7732817
    [No Abstract]   [Full Text] [Related]  

  • 8. A method for estimating prostaglandin synthetase activity in blood platelets and the extent of its pharmacological inhibition [proceedings].
    Cockbill SR; Heptinstall S
    J Physiol; 1978 Mar; 276():15P-16P. PubMed ID: 418169
    [No Abstract]   [Full Text] [Related]  

  • 9. [Positive and negative schizophrenic symptoms: a reanalysis of the dichotomous model of schizophrenia].
    Peralta Martín V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(4):266-73. PubMed ID: 2075847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unfavorable course of recurrent (schizoaffective) schizophrenia].
    Mosolov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):80-7. PubMed ID: 2158733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.
    Jackman H; Luchins D; Meltzer HY
    Biol Psychiatry; 1983 Aug; 18(8):887-902. PubMed ID: 6615945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia.
    Moran PM; Owen L; Crookes AE; Al-Uzri MM; Reveley MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):116-23. PubMed ID: 17764799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.
    Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia.
    Dror N; Klein E; Karry R; Sheinkman A; Kirsh Z; Mazor M; Tzukerman M; Ben-Shachar D
    Mol Psychiatry; 2002; 7(9):995-1001. PubMed ID: 12399953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmune assay of human platelet prostaglandin synthetase.
    Roth GJ; Machuga ET
    J Lab Clin Med; 1982 Feb; 99(2):187-96. PubMed ID: 6801166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms].
    Güleç G; Güneş E; Yenilmez C
    Turk Psikiyatri Derg; 2008; 19(3):247-56. PubMed ID: 18791877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endoperoxide prostaglandin synthetase from the microsomal fraction of human platelets].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1982 Oct; 47(10):1635-40. PubMed ID: 6816299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive, clinical, and functional characteristics of verbally superior schizophrenia patients.
    Heinrichs RW; Miles AA; Smith D; Zargarian T; Vaz SM; Goldberg JO; Ammari N
    Neuropsychology; 2008 May; 22(3):321-8. PubMed ID: 18444710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.